Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021

SELL
$446.73 - $548.2 $280,993 - $344,817
-629 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$478.3 - $607.98 $300,850 - $382,419
629 New
629 $304,000
Q1 2020

May 15, 2020

SELL
$336.18 - $494.43 $784,644 - $1.15 Million
-2,334 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$274.13 - $376.51 $639,819 - $878,774
2,334 New
2,334 $876,000

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $81.1B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Gyon Technologies Capital Management, LP Portfolio

Follow Gyon Technologies Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gyon Technologies Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Gyon Technologies Capital Management, LP with notifications on news.